Test Price
450 AED✅ Home Collection Available
Immunophenotyping by Flow Cytometry (CD38) in UAE | 450 AED | 2026 DHA Guidelines
تحليل النمط المناعي بالتدفق الخلوي (CD38) في الإمارات | 450 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Clinical Excellence & Patient Convenience
- ✔99.9% Diagnostic Sensitivity: ISO‑accredited multiparametric flow cytometry with automated gating.
- ✔ISO‑Certified Cold‑Chain Home Collection: Paid hospital‑grade phlebotomy, VIP mobile service, 8 AM–11 PM.
- ✔Same‑Day Report: Sample received by 9 AM – report issued same day by DHA‑licensed specialists.
- ✔Telephonic Post‑Test Clinical Guidance: Free 10‑minute interpretation with a hematologist.
- ✔Insurance Direct Billing: Verify coverage via WhatsApp at +971 54 548 8731 – instant confirmation.
ملخص تنفيذي: دقة تشخيصية 99.9% عبر مختبرات معتمدة دولياً، خدمة سحب منزلي فاخرة لنقل آمن بتبريد معتمد، وإرشاد سريري هاتفي بعد ظهور النتائج لتفسير معتمد من أطباء هيئة الصحة بدبي.
Overview
Immunophenotyping by Flow Cytometry for CD38 precisely quantifies the proportion of cells expressing the CD38 surface antigen, a pivotal marker in hematologic malignancies such as multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia. The test aids in diagnosis, risk stratification, and minimal residual disease (MRD) monitoring, enabling personalized therapy decisions within the UAE’s DHA‑regulated framework.
| Feature | Our CD38 Flow Cytometry Test | Closest Alternative (IHC / Single‑Marker) |
|---|---|---|
| Methodology | Multiparametric FACS with automated gating; 8‑color panel | CD38 immunohistochemistry (IHC) – qualitative, low resolution |
| Diagnostic Sensitivity | 99.9% – detects aberrant dim/strong CD38 expression | ~85% – limited to visual scoring, may miss dim populations |
| Turnaround Time | Same day (sample by 9 AM) | 2–3 working days |
| Clinical Utility | Therapy target assessment, MRD, CAR‑T eligibility | Limited to lineage confirmation |
| Regulatory Compliance | ISO 9001:2015, DHA Lab License No. 9834453, UAE PDPL | Variable accreditation |
Physician Insight & Safety Protocol
“As your hematologist, I want you to know that a CD38 immunophenotyping result is a powerful decision‑making tool. It not only confirms the clonal nature of plasma cells but also guides the use of targeted monoclonal antibodies. Please remember, every laboratory value must be interpreted within the full clinical context – never alter your treatment without a thorough discussion with your oncology team.”
— Dr. Prabhakar Reddy, Consultant Hematologist (DHA: 61713011)
⚠ Medication Warning
Do not discontinue any prescribed medication, including immunomodulatory drugs, corticosteroids, or chemotherapy, without consulting your treating physician. Abrupt cessation can cause rapid disease flare. This test is a monitoring tool; it does not replace clinical judgment.
Safety & Exclusion Criteria
Exclusion for Home Collection:
- Known severe bleeding disorder (hemophilia A/B, von Willebrand) for bone marrow procedures.
- Inability to provide informed consent or lack of a guardian for minors (UAE Child Data Security Law 2026 adhered to).
- Active infection at proposed collection site.
Emergency Red Flags – Seek Immediate Medical Attention After Bone Marrow Sampling:
- Persistent oozing or frank bleeding from puncture site for >15 minutes.
- Sudden severe pain, fever >38.5°C, or signs of local infection (redness, swelling).
- Loss of sensation or motor function in the lower limbs after posterior iliac crest aspiration.
Patient FAQ & Clinical Guidance
1. Why has my doctor ordered a CD38 immunophenotyping test?
Tip: CD38 immunophenotyping is a highly sensitive flow cytometry assay that quantifies CD38‑positive cells to diagnose, classify, and monitor plasma cell disorders such as multiple myeloma and chronic lymphocytic leukemia. It identifies target antigens for modern therapies like daratumumab and helps track minimal residual disease (MRD) after treatment, offering your UAE oncologist real‑time guidance on therapeutic effectiveness.
س: لماذا طلب طبيبي إجراء تحليل النمط المناعي CD38؟
ج: يُعد تحليل CD38 بتقنية التدفق الخلوي فائق الحساسية، وهو يُحدد بدقة نسبة الخلايا الإيجابية لـ CD38، مما يُسهم في تشخيص أمراض البلازما مثل المايلوما المتعددة وابيضاض الدم الليمفاوي المزمن، ويُستخدم لمراقبة المرض المتبقي بعد العلاج وتوجيه العلاج بالأجسام المضادة وحيدة النسيلة كالـداراتوموماب.
2. What do I need to prepare before the blood or bone marrow collection?
Tip: For peripheral blood: no fasting required; simply bring a brief clinical history note from your doctor. If bone marrow is requested, refrain from anticoagulant use as per physician advice, and arrange for a companion to drive you home. The sample must be shipped at room temperature (18–22°C) immediately; our home collection team follows cold‑chain protocols to ensure viability – never refrigerate or freeze the specimen.
س: كيف أستعد لسحب العينة الدموية أو نخاع العظم؟
ج: لا حاجة للصيام لإجراء سحب الدم؛ أحضر ملخصًا سريريًا مختصرًا من طبيبك. أما بالنسبة لنخاع العظم، فتجنب مميعات الدم حسب توجيه الطبيب، واصطحب مرافقًا للعودة. ينقل فريقنا المتخصص العينة فوراً في درجة حرارة الغرفة (18-22 مئوية) دون تبريد أو تجميد لضمان دقة الفحص.
3. How quickly will I receive my results and will a specialist explain them?
Tip: Once your sample reaches our lab by 9 AM, the report is issued the same day; the final signed PDF is shared via WhatsApp or email. Within 24 hours, you can schedule a complimentary 10‑minute telehealth consultation with a DHA‑licensed hematologist who will interpret the percentage of CD38+ cells and discuss next steps with your primary oncologist.
س: متى أتلقى النتيجة وهل يشرحها لي مختص؟
ج: تصدر النتيجة في نفس اليوم فور وصول العينة إلى المختبر قبل الساعة التاسعة صباحاً، وتُرسل بتنسيق PDF عبر الواتساب. وخلال 24 ساعة يمكنك حجز استشارة هاتفية مجانية لمدة 10 دقائق مع طبيب أمراض دم مرخص من هيئة الصحة بدبي لتفسير النسبة المئوية للخلايا الإيجابية وتنسيق الخطوة التالية مع طبيب الأورام.
✅ UAE Regulatory Compliance: This test service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87 – confidentiality of genetic/immunophenotypic data), UAE PDPL (Federal Decree‑Law No. 45 of 2021), and CDS Law 2026 regarding minor data protection. All data is stored on encrypted servers within the UAE.
✅ Accreditations: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) • DHA Laboratory License No. 9834453 • Medical Director: Dr. Prabhakar Reddy (DHA‑61713011).
✅ Price: 450 AED – includes collection, processing, specialist report, and post‑ guidance.
📞 Insurance & Booking: +971 54 548 8731 (WhatsApp) – Direct Billing Verification Available.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians